Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
CompletedPhase 4NCT06233630
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Effect of Erector Spinae Plane Block and iPACK block with Adductor Canal Block on pain management, and NLR and PLR following knee arthroplasty
Study details
- Official title
- Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
- Interventions
- Drug: Control Test - spinal anesthesia
- Drug: Ropivacaine 0.2% Injectable Solution ESPB
- Drug: Ropivacaine 0.2% Injectable Solution iPACK+ACB
- Sponsor
- Poznan University of Medical Sciences
- Start date
- 2024-03-30
- Primary completion
- 2024-08-16
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with ASA classification I-III, * Aged 20-100 years, * scheduled for knee arthroplasty under spinal anaesthesia Exclusion Criteria: * Patients who have a history of bleeding diathesis, * Take anticoagulant therapy, * have a History of chronic pain before surgery, * have Multiple trauma, * cannot assess their pain (dementia), * have been operated on under general anaesthesia, * have an infection in the area * do not accept the procedure
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06233630